Streetbeat News

Products Services

NNBR

NN, Inc. (NASDAQ:NNBR) announced $17.2 million in new business awards for Q1 2024, maintaining momentum with over 70% of these awards starting in 2024. The company is on track to meet its 2024 target of $55-$70 million in new business, with wins across North America, South America, Europe, and China. These wins are in strategic areas such as vehicle electrification, fuel efficiency, electrical grid expansion, and orthopedic medical products, contributing to NN's multi-year transformation plan for above-market profitable sales growth.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 8:12 pm

KA

Kineta's shares surged following the announcement of positive initial clinical response data from its Phase 1/2 VISTA-101 clinical trial at AACR 2024.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 8:05 pm

NIO

Whale investors have shown a bullish stance on NIO, with 77% of detected trades being bullish. The significant trades range between $4.0 to $25.0 for NIO over the next three months. NIO, a leading electric vehicle maker, has seen a trading volume of 36,894,802 with its price up by 0.68%, currently at $4.42. Analysts have given mixed ratings with an average target price of $7.275, highlighting the potential for growth and the risks involved in options trading.

Portfolio Pulse from Benzinga Insights

April 08, 2024 | 7:46 pm

JPM

JPMorgan Chase CEO Jamie Dimon highlighted the transformative potential of artificial intelligence (AI) in his annual letter, comparing its impact to historical inventions like the printing press and steam engine. He noted JPMorgan's active use of AI and machine learning in over 400 use cases across various business areas, emphasizing the technology's role in enhancing operations, employee productivity, and customer service. Dimon expressed optimism about AI's ability to augment jobs and potentially change workforce composition, despite acknowledging possible job reductions in certain areas.

Portfolio Pulse from Chris Katje

April 08, 2024 | 7:19 pm

TONUSD

Toncoin (CRYPTO: TON) surged 16.5% to a new all-time high of $6.25 following the announcement of a new palm scanning identity verification system by the TON network. This growth is attributed to several factors including a new financial reward system for Telegram channel owners announced by Telegram founder Pavel Durov and a preliminary valuation of Telegram at $30 billion. The TON network, revived in 2022 as The Open Network, has introduced this palm scanning initiative in partnership with AI company HumanCode, offering a privacy-focused method of identity verification.

Portfolio Pulse from Murtuza Merchant

April 08, 2024 | 6:49 pm

ELF

Recent options trading activity for e.l.f. Beauty (NYSE:ELF) shows a mixed sentiment among investors, with a slight bearish lean. Analysis of 11 trades reveals 45% bullish and 54% bearish positions. The focus is on a price range of $115.0 to $185.0. The largest trades include both bullish and bearish expectations, with significant activity in calls and puts. e.l.f. Beauty, a US-based cosmetics company, is currently trading at $162.0, with a neutral RSI and an anticipated earnings release in 44 days. Analysts have given mixed reviews, with an average target price of $221.25.

Portfolio Pulse from Benzinga Insights

April 08, 2024 | 6:45 pm

LGVN

Longeveron Inc (NASDAQ:LGVN) shares surged over 50% after announcing a share offering and a letter from CEO Wa’el Hashad marking his first year. The letter highlighted progress in developing Lomecel-B™ for diseases like HLHS and Alzheimer’s, success in Phase 1 trials for HLHS, ongoing Phase 2 trials, and strategic collaborations for funding. The company is seeking additional capital through a reverse stock split and registration statement to meet 2024 operational goals.

Portfolio Pulse from Henry Khederian

April 08, 2024 | 6:28 pm

CANE

The Teucrium Sugar Fund ETF (CANE) experienced a gap down in Monday's trading session amid mixed sugar price forecasts due to the El Nino weather event. El Nino historically affects sugar crop production in major producing countries like Brazil and India, leading to price fluctuations. The outlook for sugar prices is mixed, with bearish factors like increased sugarcane production in India and bullish factors like reduced production in Thailand. Technical analysis indicates CANE is in a downtrend but may bounce back in the short term.

Portfolio Pulse from Melanie Schaffer

April 08, 2024 | 6:23 pm

ESPR

Esperion Therapeutics' shares are trading lower following the announcement of new data from their CLEAR Outcomes study.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 6:21 pm

JNJ

LEGN

NVS

The FDA approved Johnson & Johnson's Carvykti for a wider population of multiple myeloma patients, marking it as the first BCMA-targeted therapy for early relapse treatment. This approval is based on the Phase 3 CARTITUDE-4 study results. Johnson & Johnson has increased Carvykti's production and plans further expansion. The company, in collaboration with Legend Biotech Corporation and Novartis AG, aims to double manufacturing by 2024. Despite Carvykti's current market lead, challenges from newer BCMA-targeted therapies could impact its dominance.

Portfolio Pulse from Vandana Singh

April 08, 2024 | 6:19 pm